Key facts today
Pfizer's Q1 adjusted earnings were $0.92 per share, surpassing estimates. Revenue was $13.72 billion, below expectations. Shares rose about 3.8% post-report, with 2025 earnings guidance maintained.
Pfizer's Q1 revenue was $13.7 billion, missing forecasts. Paxlovid sales fell 76% to $491 million, while Comirnaty sales increased 60% to $565 million. Primary care revenue dropped 21%.
Pfizer's CEO Albert Bourla stated that uncertainty over potential higher tariffs on drug imports is limiting the company's investments in US research, development, and manufacturing this year.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.370 EUR
7.75 B EUR
61.46 B EUR
5.67 B
About Pfizer
Sector
Industry
CEO
Albert Bourla
Website
Headquarters
New York
Founded
1849
FIGI
BBG000QFV6P2
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Pfizer Stock Chart Fibonacci Analysis 042925Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 22.7/61.80%
Chart time frame:D
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress: C
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) 61.80% support
D) Hit the bottom
Tensions in the Pharma Sector and Signs of U.S. StagflationBy Ion Jauregui – Analyst at ActivTrades
The U.S. biopharmaceutical industry may soon face significant regulatory changes. According to sector sources, the Trump administration is evaluating a proposal to tie U.S. drug prices to the lowest prices available in other developed countries. This initiati
PFEAt the current price, I'm looking for a retest toward the daily target zone located on the chart. On 3/21 PFE announced news about dropping the decision to move forward with the weight loss drug. Since then, price dropped down in spike like fashion. After the big volume spike, on that date, volume c
OptionsMastery: Looking like more downside on PFE!🔉Sound on!🔉
📣Make sure to watch fullscreen!📣
Thank you as always for watching my videos. I hope that you learned something very educational! Please feel free to like, share, and comment on this post. Remember only risk what you are willing to lose. Trading is very risky but it can change your life!
The Collaborative Edge: Pfizer's Innovation Secret? Pfizer's success in the biopharmaceutical industry hinges on its internal capabilities and a strategic embrace of external collaboration. This proactive approach, spanning diverse technological frontiers, fuels innovation across its operations. From partnering with QuantumBasel and D-Wave to optimiz
12/23/24 - PFE: new BUY mechanical signal.12/23/24 - PFE: new BUY signal chosen by a rules based, mechanical trading system.
PFE - BUY
Stop Loss @ 24.80
Entry BUY @ 26.71
Target Profit @ 29.54
Analysis:
1. On the Higher timeframe - Prices have stayed above the lower channel line of the ATR (Average True Range) Channel
2. Higher timefram
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063Yield to maturity
6.04%
Maturity date
May 19, 2063
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053Yield to maturity
5.92%
Maturity date
May 19, 2053
See all 4PFE bonds
Curated watchlists where 4PFE is featured.
Related stocks
Frequently Asked Questions
The current price of 4PFE is 20.946 EUR — it has increased by 2.82% in the past 24 hours. Watch PFIZER stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange PFIZER stocks are traded under the ticker 4PFE.
4PFE stock has risen by 8.76% compared to the previous week, the month change is a −10.68% fall, over the last year PFIZER has showed a −12.78% decrease.
We've gathered analysts' opinions on PFIZER future price: according to them, 4PFE price has a max estimate of 28.98 EUR and a min estimate of 19.32 EUR. Watch 4PFE chart and read a more detailed PFIZER stock forecast: see what analysts think of PFIZER and suggest that you do with its stocks.
4PFE reached its all-time high on Dec 20, 2021 with the price of 53.720 EUR, and its all-time low was 18.876 EUR and was reached on Apr 11, 2025. View more price dynamics on 4PFE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4PFE stock is 2.75% volatile and has beta coefficient of 0.29. Track PFIZER stock price on the chart and check out the list of the most volatile stocks — is PFIZER there?
Today PFIZER has the market capitalization of 114.82 B, it has increased by 1.80% over the last week.
Yes, you can track PFIZER financials in yearly and quarterly reports right on TradingView.
PFIZER is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
4PFE earnings for the last quarter are 0.85 EUR per share, whereas the estimation was 0.62 EUR resulting in a 38.23% surprise. The estimated earnings for the next quarter are 0.50 EUR per share. See more details about PFIZER earnings.
PFIZER revenue for the last quarter amounts to 12.68 B EUR, despite the estimated figure of 12.87 B EUR. In the next quarter, revenue is expected to reach 11.87 B EUR.
4PFE net income for the last quarter is 389.29 M EUR, while the quarter before that showed 4.02 B EUR of net income which accounts for −90.31% change. Track more PFIZER financial stats to get the full picture.
Yes, 4PFE dividends are paid quarterly. The last dividend per share was 0.41 EUR. As of today, Dividend Yield (TTM)% is 7.33%. Tracking PFIZER dividends might help you take more informed decisions.
PFIZER dividend yield was 6.37% in 2024, and payout ratio reached 119.94%. The year before the numbers were 5.73% and 444.50% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 30, 2025, the company has 81 K employees. See our rating of the largest employees — is PFIZER on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PFIZER EBITDA is 23.32 B EUR, and current EBITDA margin is 36.93%. See more stats in PFIZER financial statements.
Like other stocks, 4PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PFIZER stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PFIZER technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PFIZER stock shows the strong sell signal. See more of PFIZER technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.